Eric R. Olson

Eric R. Olson is a declared insider of Syros Pharmaceuticals, Inc. (senior executive), with filings sourced from SEC (Form 4). The record holds 5 filings, for trades running from 1 July 2021 to 17 July 2023.

Every open-market trade on record is a sale: 3 sales worth €2,146. No amount is published for 2 filings, which the totals therefore leave out. Besides market trades, the filings include 1 share grant and 1 option exercise. Since January 2023: no purchases and 1 sale on the market.

The record was last updated on 18 July 2023 with an open-market sale (€2,146) in Syros Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.